You are here

Venclexta

In label expansion bid, AbbVie and Roche's Venclexta falls short in multiple myeloma subset

Fierce Pharma

Fri, 09/29/23 - 12:13 pm

Multiple Myeloma

How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market

Motley Fool

Thu, 07/29/21 - 11:12 am

breakthrough therapy

In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment

Endpoints

Mon, 06/14/21 - 10:29 am

clinical trials

FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies

Pharmaforum

Mon, 10/19/20 - 10:56 am

clinical trials

EHA: AbbVie, Roche cement Venclexta's place in AML with survival win

Fierce Pharma

Sat, 06/13/20 - 11:32 pm

AbbVie announces positive topline results from phase 3 trial of VENCLEXTA, Azacitidine combo in AML

Pharmaceutical Business Review

Tue, 03/24/20 - 10:45 am

clinical trials

AbbVie, Roche's Venclexta nails confirmatory combo trial in AML after flopping earlier study

Fierce Pharma

Mon, 03/23/20 - 11:53 am

clinical trials

AbbVie, Roche's Venclexta endangers AML approval with flopped confirmatory trial

Fierce Pharma

Mon, 03/2/20 - 11:07 pm

ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL

Fierce Pharma

Sun, 12/8/19 - 10:12 pm

Roche and Celgene set for battle in acute myelogenous leukaemia

EP Vantage

Wed, 09/18/19 - 09:54 am

acute myeloid leukemia

5 Things You Need to Know From AbbVie's Q2 Earnings Results

Motley Fool

Sat, 07/27/19 - 02:03 pm

FDA lifts hold on AbbVie multiple myeloma study

Biopharma Dive

Tue, 06/25/19 - 07:19 pm

clinical trials

Multiple Myeloma

AbbVie gets a green light to resume recruiting patients for one myeloma study — but Venclexta remains under a cloud

Endpoints

Mon, 06/24/19 - 10:54 am

Multiple Myeloma

clinical trials

ASCO Soundbites, vol. 3: Real-time approvals, Pfizer's second rodeo and 'the busiest ASCO ever'

Fierce Pharma

Tue, 06/4/19 - 12:18 pm

AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva

Fierce Pharma

Thu, 05/16/19 - 10:53 am

small lymphocytic leukemia

2 Things Investors Are Missing About AbbVie

Motley Fool

Sun, 03/17/19 - 01:29 pm

Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia

CP Wire

Thu, 03/7/19 - 09:53 am

chronic lymphocytic leukemia

Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia

Thu, 03/7/19 - 09:35 am

chronic lymphocytic leukemia

AbbVie’s cancer drug Venclexta blocks diabetes in mice by targeting beta cell ‘senescence’

Fierce Biotech

Fri, 02/22/19 - 11:50 am

type 1 diabetes

AbbVie, Roche aim to face down Pfizer with Venclexta’s move into AML arena

Fierce Pharma

Mon, 11/26/18 - 12:35 pm

Pages